Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats.

Abstract

Treatment with cyclosporin A was most effective in abrogating popliteal-lymph-node enlargement induced by host-versus-graft and graft-versus-host reactivity in rats when started before injection of donor-strain lymphocytes. Popliteal lymph-node enlargement was never completely abolished, and splenic lymphocytes from recipients treated with cyclosporin A showed no significant reduction in their response to donor-strain lymphocytes in mixed lymphocyte cultures, suggesting that clonal deletion had not taken place. Mixed lymphocyte cultures also indicated that cyclosporin treatment had not reduced the antigenicity of recipient lymphocytes towards donor strain.

Statistics

050001000015000'80'83'87'91'95'99'03'07'11'15
Citations per Year

1,480 Citations

Semantic Scholar estimates that this publication has 1,480 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Markwick1979TimingOC, title={Timing of cyclosporin-A therapy for abrogation of HVG and GVH responses in rats.}, author={J. R. Markwick and Jordan D. Chambers and John R. Hobbs and G. D. Pegrum}, journal={Lancet}, year={1979}, volume={2 8151}, pages={1037-40} }